Cholangiocarcinomas Active Not Recruiting Phase 1 Trials for Taladegib (DB12550)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02784795A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsTreatment